Perioperative Safety and Efficacy of Efgartigimod for Thymoma-Associated Myasthenia Gravis: A Prospective, Multicenter, Phase II Clinical Trial

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (82472924, 82404059)
  • National Key Research and Development Program of China (2023YFC3402700)

This publication has 25 references indexed in Scilit: